{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:05:38Z","timestamp":1784127938954,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["23-07570S"],"award-info":[{"award-number":["23-07570S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cbi.2025.111548","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T06:24:42Z","timestamp":1746253482000},"page":"111548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["ADMET parameters of tacrine and its metabolites confirm unsuitability of Sus scrofa f. domestica model to study tacrine-associated hepatotoxicity"],"prefix":"10.1016","volume":"416","author":[{"given":"M.","family":"Novak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bure\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Radochov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pejchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Prchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6376-8701","authenticated-orcid":false,"given":"O.","family":"Soukup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cbi.2025.111548_bib1","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.3891\/acta.chem.scand.15-1386","article-title":"Inhibition of cholinesterases by tetrahydroaminacrin","volume":"15","author":"Heilbronn","year":"1961","journal-title":"Acta Chem. Scand."},{"issue":"8748","key":"10.1016\/j.cbi.2025.111548_bib2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/0140-6736(91)92656-M","article-title":"Tacrine in alzheimer\u2019s disease","volume":"337","author":"Eagger","year":"1991","journal-title":"Lancet"},{"issue":"S139","key":"10.1016\/j.cbi.2025.111548_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0404.1992.tb04458.x","article-title":"Putative mechanisms of action of tacrine in Alzheimer's disease","volume":"85","author":"Adem","year":"1992","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.cbi.2025.111548_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pnpbp.2017.01.003","article-title":"The pharmacology of tacrine at N -methyl- d -aspartate receptors","volume":"75","author":"Horak,","year":"2017","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"issue":"13","key":"10.1016\/j.cbi.2025.111548_bib5","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/jama.1994.03510370037029","article-title":"A 30-week randomized controlled trial of high-dose tacrine in patients with alzheimer\u2019s disease. The tacrine study group","volume":"271","author":"Knapp,","year":"1994","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cbi.2025.111548_bib6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2165\/00023210-199504030-00002","article-title":"Tacrine-induced hepatotoxicity: tolerability and management","volume":"4","author":"Balson","year":"1995","journal-title":"CNS Drugs"},{"key":"10.1016\/j.cbi.2025.111548_bib7","doi-asserted-by":"crossref","first-page":"115154","DOI":"10.1016\/j.jpba.2022.115154","article-title":"UHPLC-orbitrap study of the first phase tacrine in vitro metabolites and related alzheimer\u2019s drug candidates using human liver microsomes","volume":"224","author":"Novak,","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"8","key":"10.1016\/j.cbi.2025.111548_bib8","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/BF01291795","article-title":"Velnacrine for the treatment of Alzheimer's disease: a double-blind, placebo-controlled trial","volume":"103","author":"Zemlan","year":"1996","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.cbi.2025.111548_bib9","first-page":"9","article-title":"et at.,Bioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations","author":"Woolf,","year":"1993","journal-title":"Drug Metabol. Dispos."},{"issue":"4","key":"10.1016\/j.cbi.2025.111548_bib10","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2174\/138920008784220619","article-title":"et al., Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer\u2019s disease","volume":"9","author":"Patocka,","year":"2008","journal-title":"Curr. Drug Metabol."},{"issue":"1","key":"10.1016\/j.cbi.2025.111548_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/00498259509061837","article-title":"et al., Species Variation in the bioactivation of tacrine by hepatic microsomes","volume":"25","author":"Madden,","year":"1995","journal-title":"Xenobiotica"},{"issue":"9","key":"10.1016\/j.cbi.2025.111548_bib12","doi-asserted-by":"crossref","DOI":"10.1021\/acschembio.3c00219","article-title":"Tacrine first-phase biotransformation and associated hepatotoxicity: a possible way to avoid quinone methide formation","volume":"18","author":"Novak","year":"2023","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"10.1016\/j.cbi.2025.111548_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004850-199200710-00004","article-title":"Pharmacokinetics of tetrahydroaminoacridine: relations to clinical and biochemical effects in alzheimer patients","volume":"7","author":"Ahlin","year":"1992","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.cbi.2025.111548_bib14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2165\/00003088-199528060-00003","article-title":"Clinical pharmacokinetics of tacrine","volume":"28","author":"Madden","year":"1995","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.cbi.2025.111548_bib15","doi-asserted-by":"crossref","first-page":"25187","DOI":"10.1038\/srep25187","article-title":"Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease","volume":"6","author":"Bell","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2025.111548_bib16","article-title":"Primary human hepatocyte spheroids as an in vitro tool for investigating drug compounds with low clearance","volume":"DMD-AR-2020-000340","author":"Riede","year":"2021","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.cbi.2025.111548_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1208\/s12248-022-00689-y","article-title":"Multi-well array culture of primary human hepatocyte spheroids for clearance extrapolation of slowly metabolized compounds","volume":"24","author":"Preiss","year":"2022","journal-title":"AAPS J"},{"issue":"6","key":"10.1016\/j.cbi.2025.111548_bib18","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1096\/fj.201601375R","article-title":"Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long-term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics","volume":"31","author":"Vorrink","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.cbi.2025.111548_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117678","article-title":"Novel tacrine-based multi-target directed Ligands: enhancing cholinesterase inhibition, NMDA receptor antagonism, and CNS bioavailability for Alzheimer\u2019s disease treatment","volume":"292","author":"Svobodova,","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.cbi.2025.111548_bib20","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2174\/1568026605666160927152728","article-title":"et al., Multitarget tacrine hybrids with neuroprotective properties to confront Alzheimer\u2019s disease","volume":"17","author":"Spilovska,","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"issue":"3","key":"10.1016\/j.cbi.2025.111548_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00315027","article-title":"Clinical pharmacokinetics of intravenous and oral 9-amino-1,2,3,4-tetrahydroacridine, tacrine","volume":"38","author":"Hartvig","year":"1990","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.cbi.2025.111548_bib22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/jac\/dkn231","article-title":"Pharmacokinetics of artesunate in the domestic pig","volume":"62","author":"Sinou","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.cbi.2025.111548_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3565(25)22379-5","article-title":"Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 caucasians","volume":"270","author":"Shimada","year":"1994","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"16","key":"10.1016\/j.cbi.2025.111548_bib24","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1080\/10408398.2020.1784841","article-title":"et al., Mechanisms, physiology, and recent research progress of gastric emptying","volume":"61","author":"Liu,","year":"2021","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.cbi.2025.111548_bib25","doi-asserted-by":"crossref","first-page":"105627","DOI":"10.1016\/j.ejps.2020.105627","article-title":"et al.,Characterization of gastrointestinal transit and luminal conditions in pigs using a telemetric motility capsule","volume":"156","author":"Henze","year":"2021","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"1","key":"10.1016\/j.cbi.2025.111548_bib26","doi-asserted-by":"crossref","first-page":"9233","DOI":"10.1038\/s41598-019-45212-0","article-title":"Characterization of porcine hepatic and intestinal drug metabolizing CYP450: comparison with human orthologues from A quantitative, activity and selectivity perspective","volume":"9","author":"Schelstraete","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2025.111548_bib27","series-title":"et al., Physiology of the pineal gland and melatonin, Endotext, MDText.com","author":"Arendt,","year":"2000"},{"key":"10.1016\/j.cbi.2025.111548_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-386454-3.00198-6","article-title":"Tacrine - an overview","author":"Gupta","year":"2014","journal-title":"Encyclopedia of Toxicology"},{"issue":"4","key":"10.1016\/j.cbi.2025.111548_bib29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/bcpt.13944","article-title":"et al.,BCPT 2023 policy for experimental and clinical studies","volume":"133","author":"Tveden-Nyborg","year":"2023","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.cbi.2025.111548_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"et al.,Improving bioscience research reporting: the ARRIVE Guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol"},{"issue":"3","key":"10.1016\/j.cbi.2025.111548_bib32","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Methods Progr. Biomed."},{"issue":"4","key":"10.1016\/j.cbi.2025.111548_bib33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3109\/09553002.2012.654044","article-title":"Activation of p38 MAPK and expression of TGF-B1 in rat colon enterocytes after wholy body \u03b3-irradiation","volume":"88","author":"Pejchal","year":"2012","journal-title":"Int. J. Radiat. Biol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725001784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725001784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T07:55:12Z","timestamp":1748332512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279725001784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":32,"alternative-id":["S0009279725001784"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111548","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADMET parameters of tacrine and its metabolites confirm unsuitability of Sus scrofa f. domestica model to study tacrine-associated hepatotoxicity","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111548","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111548"}}